Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The role of the CpG island methylator phenotype on survival outcome in colon cancer.

Gut and liver - 1 Mar 2015

Kang Ki Joo, Min Byung Hoon, Ryu Kyung Ju, Kim Kyoung Mee, Chang Dong Kyung, Kim Jae J, Rhee Jong Chul, Kim Young Ho

Abstract excerpt

BACKGROUND/AIMS: CpG island methylator phenotype (CIMP)- high colorectal cancers (CRCs) have distinct clinicopathologi-cal features from their CIMP-low/negative CRC counterparts. However, controversy exists regarding the prognosis of CRC according to the CIMP status. Therefore, this study examined the prognosis of Korean patients with colon cancer according to the CIMP status. METHODS: Among a previous cohort...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CpG Islands
Share to DNA Methylation
Share to Microsatellite Instability

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Multivariate Analysis

Share to Neoplasm Staging

Share to Republic of Korea

Share to Sex Factors

Share to Survival Analysis

Source

Open in PubMed Open full text

Identifiers

PMID: 25167802
DOI: 10.5009/gnl13352
PMCID: PMC4351027

Genes

IGF2
NEUROG1
RUNX3
SOCS1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The role of the CpG island methylator phenotype on survival outcome in colon cancer.PMID 25167802Read ↗

Adverse prognostic impact of the CpG island methylator phenotype in metastatic colorectal cancer.Semantic proximity Read ↗

CpG island methylator phenotype identifies high risk patients among microsatellite stable BRAF mutated colorectal cancers.Semantic proximity Read ↗

Meta-Analysis of the Prognostic and Predictive Role of the CpG Island Methylator Phenotype in Colorectal Cancer.Semantic proximity Read ↗

The CpG island methylator phenotype may confer a survival benefit in patients with stage II or III colorectal carcinomas receiving fluoropyrimidine-based adjuvant chemotherapy.Semantic proximity Read ↗

Unique characteristics of CpG island methylator phenotype (CIMP) in a Chinese population with colorectal cancer.Semantic proximity Read ↗

CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer.Semantic proximity Read ↗

Epigenetic alterations in colorectal cancer: the CpG island methylator phenotype.Semantic proximity Read ↗

CpG Island Methylator Phenotype(CIMP) is An Independent Prognostic Marker with Tumor-Promoting Functions in Colorectal CancerSemantic proximity Read ↗

CpG island methylator phenotype is an independent predictor of survival after curative resection for colorectal cancer: A prospective cohort study.Semantic proximity Read ↗

No association of CpG island methylator phenotype and colorectal cancer survival: population-based study.Semantic proximity Read ↗

Different definitions of CpG island methylator phenotype and outcomes of colorectal cancer: a systematic review.Semantic proximity Read ↗

Comprehensive biostatistical analysis of CpG island methylator phenotype in colorectal cancer using a large population-based sample.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.